Praxis Precision Medicines
Manufacturing · Massachusetts, United States · 51-200 Employees
View Company Info for Free
Overview
Headquarters
99 High St Ste 30, Boston, Massachusetts...Phone Number
(617) 300-8460Website
www.praxismedicines.comRevenue
$7.5 MillionStock Symbol
PRAXIndustry
About Praxis Precision Medicines
Praxis Precision Medicines is a clinical-stage biopharmaceutical company translating genetic insights into the development of therapies for CNS disorders characterized by neuronal excitation-inhibition imbalance. Praxis is applying insights from genetic epilepsies to both rare and more prevalent neurological and psychiatric disorders, using our understanding of shared biological targets and circuits in the brain. Praxis has established a broad portfolio with multiple programs, including product candidates across psychiatric disorders, movement disorders, epilepsy and other CNS indications, with three clinical-stage product candidates.Explore more
Praxis Precision Medicines Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Compare Similar Companies to Praxis Precision Medicines
Compare insights from companies similar to Praxis Precision Medicines, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Praxis Precision Medicines Tech Stack
A closer look at the technologies used by Praxis Precision Medicines
See more technologies
Top Manufacturing Companies
Top companies in Canada by revenue
Frequently Asked Questions Regarding Praxis Precision Medicines
Sign Up For FreeTo access detailed company insights
Praxis Precision Medicines is a clinical-stage biopharmaceutical company translating genetic insights into the development of therapies for CNS disorders characterized by neuronal excitation-inhibition imbalance. Praxis is applying insights from genetic epilepsies to both rare and more prevalent neurological and psychiatric disorders, using our und... Read More
